Development of an assay for detection of Circulating Endothelial Cell (CEC) and Circulating Endothelial Progenitor cell (CEP) by fluorescence-activated cell sorting (FACS) in cancer patients and healthy individuals. - Development and validation of the CEC/CEP FACS assay

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 70 人开始时间: 待定最近更新: 2024年4月23日

适应症

试验速览

暂无简介。

•bInclusion criteria cancer patients:
•1. Patients with histological or cytological proof of metastatic cancer.
•2. Age * 18 years
•3. Able and willing to give written informed consent
•4. Able and willing to undergo blood sampling ;Inclusion criteria healthy volunteers:
•1. Age * 18 years
•2. Able and willing to give written informed consent
•3. Able and willing to undergo blood sampling

•Exclusion criteria cancer patients:
•1. Patients with known alcoholism, drug addiction, psychotic disorders in the history and/or other reasons, for which they are not amenable for adequate follow up.
•2. Uncontrolled infectious disease or known HIV-1 or HIV-2 type patients ;Exclusion criteria healthy volunteers:
•1. Patients with known alcoholism, drug addiction, psychotic disorders in the history and/or other reasons, for which they are not amenable for adequate follow up.
•2. Uncontrolled infectious disease or known HIV-1 or HIV-2 type patients
•3. Prior history of malignancy, renal disease, cardiovascular disease.

发起方

Antoni van Leeuwenhoek Ziekenhuis